Nasdaq: IBRX
ImmunityBio insiders
The officers, directors and 10% owners of ImmunityBio, Inc. who hold the most stock, valued at the live IBRX price.
$6.57
IBRX today −$130K (−1.94%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 4
- Their IBRX stock
- $3.06B
- Market value
- $7.10B
- Held by ranked insiders
- 43.1%
Insiders by value of IBRX holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | California Capital Equity, LLC | 10% owner | 212,435,048 | $1.40B | 19.7% | Corporate |
| 2 | MP 13 Ventures, LLC | 10% owner | 166,550,284 | $1.09B | 15.4% | Corporate |
| 3 | Nant Capital, LLC | 10% owner | 83,883,815 | $551M | 7.77% | Corporate |
| 4 | Barry J. Simon | Director | 2,777,788 | $18.3M | 0.26% | 5566th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for ImmunityBio; see each profile for the filing.